Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN4A | P35499 | 4/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1991285 | 0.86 | SCN4A (0.38) | SCN4AESR1CYP1A2CYP2A6CA1 | |
| SCHEMBL14708718 | 0.81 | GABRA1 (0.43) | SCN4AESR1CYP1A2CYP2A6CA1 | |
| SCHEMBL4460481 | 0.77 | CYP2A6 (0.45) | SCN4ACYP1A2CYP2A6CA1CA2 | |
| SCHEMBL1993383 | 0.75 | GABRA1 (0.38) | ALDH1A1TSHR | |
| SCHEMBL16955883 | 0.73 | ADRA2A (0.43) | ESR1CYP1A2CYP2A6CA1CA2 | |
| SCHEMBL256732 | 0.72 | ESR1 (0.54) | ESR1CYP1A2CYP2A6CA1CA2 | |
| SCHEMBL28762439 | 0.71 | SCN4A (0.38) | SCN4ACYP1A2CYP2A6CA1CA2 | |
| SCHEMBL22564870 | 0.71 | ACHE (0.50) | SCN4ACYP1A2CYP2A6CA1CA2 | |
| SCHEMBL6735223 | 0.71 | CYP2A6 (0.36) | SCN4ACYP1A2CYP2A6CA1CA2 | |
| SCHEMBL16951322 | 0.71 | ACHE (0.39) | ESR1CYP1A2CYP2A6CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140018377-A1 | Aminopropenoates as Fungicides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-01-16 | — | — | US | disclosed |
| US-8476197-B2 | Aminopropenoates as fungicides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-07-02 | — | — | US | disclosed |
| US-20110152322-A1 | Aminopropenoates as Fungicides | BAYER CROPSCIENCE AG (DE) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152322-A1 | Aminopropenoates as Fungicides | AASDHPPT, DAO, AAAS | SCN4A 2215/4885ESR1 3000/4885CYP1A2 59/4885 |
| US-20140018377-A1 | Aminopropenoates as Fungicides | ACMSD, AASDHPPT, AAAS | SCN4A 2120/4885ESR1 3945/4885CYP1A2 164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.